{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:24:58Z","timestamp":1788992698908,"version":"build-2803163510"},"reference-count":41,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective prevention and treatment are urgently needed, since gastric cancer (GC) poses a grave threat to the health and well-being of patients. The 5 East Asian countries (China, Japan, North Korea, South Korea, and Mongolia) represent one of the most significant regions globally in terms of GC burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The goal of this study is to examine the patterns and trends of GC across 5 East Asian countries between 1990 and 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrieved data from the Global Burden of Disease Study (GBD) 2021 regarding the prevalence, incidence, mortality, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs) associated with GC in 5 East Asian countries from 1990 to 2021. We further assessed the burden of GC according to age and sex. We used decomposition analysis to examine the changes in the number of new cases, patients, and deaths related to GC. We also used Joinpoint (Joinpoint Regression Program, Version 5.1.0) and age-period-cohort analysis methods to interpret the epidemiological characteristics of GC. Autoregressive integrated moving average model (ARIMA) and Bayesian age-period-cohort (BAPC) prediction models were used to forecast the GC burden by 2036.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 5 East Asian countries, China recorded the highest incidence, prevalence, death, YLLs, YLDs, and DALYs in both 1990 and 2021. From 1990 to 2021, the age-standardized rates for prevalence, mortality, incidence, YLDs, YLLs, and DALYs across the 5 East Asian countries showed an overall decline, though they remained higher than the global average. In all 5 East Asian countries, individuals aged 65 years and older consistently exhibited the highest rates for prevalence, incidence, mortality, YLDs, YLLs, and DALYs. The prevalence rate in South Korea, the incidence rate in North Korea and Mongolia, and the mortality rate in China are influenced by aging, surpassing the global aging average.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The disease burden of GC in the 5 East Asian countries has consistently ranked high over the past 3 decades, particularly among the older individuals. The burden of GC in the 5 East Asian countries is expected to present a major public health challenge, primarily driven by the large population size and the aging demographic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/74389","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T01:25:06Z","timestamp":1752715506000},"page":"e74389-e74389","source":"Crossref","is-referenced-by-count":9,"title":["Burden and Future Trends of Gastric Cancer in 5 East Asian Countries From 1990 to 2036: Epidemiological Study Analysis Using the Global Burden of Diseases Study 2021"],"prefix":"10.2196","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-2328","authenticated-orcid":false,"given":"Tianhao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3880-4935","authenticated-orcid":false,"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9677-3047","authenticated-orcid":false,"given":"Wenjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3446-2402","authenticated-orcid":false,"given":"Yumo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-9449","authenticated-orcid":false,"given":"Yifan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5292-661X","authenticated-orcid":false,"given":"Wenjian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-3296","authenticated-orcid":false,"given":"Weixing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-3117","authenticated-orcid":false,"given":"Liu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8572-921X","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3329-2225","authenticated-orcid":false,"given":"Haibo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3878-3471","authenticated-orcid":false,"given":"Xiaoyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","journal-title":"CA A Cancer J Clinicians"},{"issue":"1","key":"R2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"R4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"R5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","journal-title":"CA Cancer J Clin"},{"issue":"10440","key":"R6","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Naghavi","journal-title":"The Lancet"},{"issue":"35","key":"R7","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-A Gift from traditional Chinese medicine to the world (nobel lecture)","volume":"55","author":"Tu","journal-title":"Angew Chem Int Ed Engl"},{"issue":"10440","key":"R8","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","article-title":"Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Schumacher","journal-title":"Lancet"},{"issue":"2","key":"R9","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311X00016616","article-title":"Burden of cancer mortality and differences attributable to demographic aging and risk factors in Argentina, 1986-2011","volume":"33","author":"Pou","journal-title":"Cad Saude Publica"},{"issue":"10159","key":"R10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","journal-title":"The Lancet"},{"issue":"4","key":"R11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study","volume":"3","author":"Fitzmaurice","journal-title":"JAMA Oncol"},{"issue":"10053","key":"R12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","journal-title":"The Lancet"},{"issue":"2","key":"R13","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","journal-title":"Lancet Public Health"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101078","article-title":"Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the Global Burden of Disease Study 2021","volume":"46","author":"Xu","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"R15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019","volume":"16","author":"Li","journal-title":"Clin Kidney J"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/j.compeleceng.2019.04.013","article-title":"A smart system for short-term price prediction using time series models","volume":"76","author":"Nguyen","journal-title":"Comput Electr Eng"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216127","article-title":"Burden of gastrointestinal cancers in China from 1990 to 2019 and projection through 2029","volume":"560","author":"Chen","journal-title":"Cancer Lett"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/gutjnl-2024-333227","article-title":"Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021","volume":"74","author":"Danpanichkul","journal-title":"Gut"},{"issue":"9","key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29929","article-title":"Global association of incidence between atrial fibrillation and the major gastrointestinal cancers: an analysis based on the 2019 Global Burden of Disease Study","volume":"10","author":"Huang","journal-title":"Heliyon"},{"issue":"12","key":"R20","doi-asserted-by":"publisher","first-page":"e1489","DOI":"10.1016\/S2214-109X(20)30358-2","article-title":"Burden of non-communicable diseases from infectious causes in 2017: a modelling study","volume":"8","author":"Coates","journal-title":"Lancet Glob Health"},{"issue":"4","key":"R21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s10120-024-01494-6","article-title":"Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019","volume":"27","author":"Li","journal-title":"Gastric Cancer"},{"issue":"22","key":"R22","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.7150\/jca.62734","article-title":"Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study","volume":"12","author":"Zhang","journal-title":"J Cancer"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s13167-022-00308-y","article-title":"Global burden of cancers attributable to tobacco smoking, 1990-2019: an ecological study","volume":"14","author":"Sharma","journal-title":"EPMA J"},{"issue":"March","key":"R24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18332\/tid\/183803","article-title":"The global, regional, and national burden of stomach cancer attributed to smoking in 204 countries, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"22","author":"Ren","journal-title":"Tob Induc Dis"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2023.102517","article-title":"Trends in gastric cancer incidence and mortality in Asia and association analysis with human development index, 1990-2019","volume":"88","author":"Zhang","journal-title":"Cancer Epidemiol"},{"issue":"24","key":"R26","doi-asserted-by":"publisher","DOI":"10.3390\/nu15245088","article-title":"The burden of gastric cancer attributable to high sodium Intake: a longitudinal study from 1990 to 2019 in China","volume":"15","author":"Jiang","journal-title":"Nutrients"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.2196\/48449","article-title":"Secular trends in gastric and esophageal cancer attributable to dietary carcinogens from 1990 to 2019 and projections until 2044 in China: population-based study","volume":"9","author":"Guo","journal-title":"JMIR Public Health Surveill"},{"issue":"3","key":"R28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.21037\/jgo-24-10","article-title":"Gastric and colorectal cancer incidence attributable to dietary factors in Korea","volume":"15","author":"Cho","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"R29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41588-023-01333-x","article-title":"Multiancestry genomic and transcriptomic analysis of gastric cancer","volume":"55","author":"Totoki","journal-title":"Nat Genet"},{"issue":"4","key":"R30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/SLA.0000000000005970","article-title":"Unique genomic alterations and microbial profiles identified in patients with gastric cancer of African, European, and Asian ancestry: a novel path for precision oncology","volume":"278","author":"Abate","journal-title":"Ann Surg"},{"issue":"2","key":"R31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.21147\/j.issn.1000-9604.2021.02.05","article-title":"Screening for gastric cancer in China: Advances, challenges and visions","volume":"33","author":"Fan","journal-title":"J Cancer Res"},{"issue":"1","key":"R32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60122-6","article-title":"The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis","volume":"14","author":"Cai","journal-title":"Sci Rep"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45859-w","article-title":"Evaluation of optimal methods and ancestries for calculating polygenic risk scores in East Asian population","volume":"13","author":"Kim","journal-title":"Sci Rep"},{"issue":"2","key":"R34","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000676","article-title":"Genomic differentiation within East Asian Helicobacter pylori","volume":"8","author":"You","journal-title":"Microb Genom"},{"issue":"1","key":"R35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10433-8","article-title":"An Investigation on attributes of ambient temperature and diurnal temperature range on mortality in five East-Asian countries","volume":"7","author":"Lee","journal-title":"Sci Rep"},{"issue":"10","key":"R36","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","journal-title":"Ann Oncol"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155169","article-title":"Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through increase of reactive oxygen species levels and suppression of proteasome activities","volume":"123","author":"Deng","journal-title":"Phytomedicine"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156003","article-title":"Mechanisms of traditional Chinese medicine in the treatment and prevention of gastric cancer","volume":"135","author":"Liu","journal-title":"Phytomedicine"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2017.02.004","article-title":"Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: a nationwide retrospective matched-cohort study","volume":"199","author":"Hung","journal-title":"J Ethnopharmacol"},{"key":"R40","unstructured":"IHME. URL: https:\/\/www.healthdata.org\/ [Accessed 20-08-2025]"},{"key":"R41","unstructured":"VizHub - GBD results. IHME. URL: https:\/\/vizhub.healthdata.org\/gbd-results\/ [Accessed 20-08-2025]"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e74389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:05:33Z","timestamp":1782842733000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e74389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":41,"URL":"https:\/\/doi.org\/10.2196\/74389","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"v11i3e74389"}}